AzTrials
AzTrials

Attention Deficit Hyperactivity DisordersADHDNCT00966394

Salivary Bacteria and Oral Health Status in Children With ADHD

An observational study of Attention Deficit Hyperactivity Disorders and Caries, Dental, run by Hadassah Medical Organization at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Attention deficit and hyperactivity (ADHD) affect 6% of school-aged children. Few studies reported higher prevalence of caries and restorations among children with ADHD. Methylphenidate is the drug of choice to treat ADHD. according to the medical literature methylphenidate can cause xerostomia. Read more about this study

Who is it for?
Ages 5 to 18 yearsHealthy volunteers can take part
How many people
150 participants
Where
1 siteIsrael
Study dates
Nov 2009to May 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Children with ADHD, treated by medications or not, treated in the neurologic clinic at Hadassah. The control are healthy children visiting the pediatric dental clinic at Hadassah.

Who may be able to join

  • test group- diagnosis of ADHD.
  • control group- ASA1

Who cannot join

  • control group
  • administration of medicine at the time of the check-up.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Hadassah school of dental medicine

    Jerusalem, 91120

Other trials in Israel

About this study

Official title: Changes in Salivary Bacteria and Oral Health Status in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit and hyperactivity (ADHD) affect 6% of school-aged children. Few studies reported higher prevalence of caries and restorations among children with ADHD. Methylphenidate is the drug of choice to treat ADHD. according to the medical literature methylphenidate can cause xerostomia.

Our study will investigate saliva parameters (such as quantity, bacteria in saliva, buffer capacity), oral hygiene and diet habits and their influence on caries among children with ADHD and among healthy children.

Read more

Our hypothesis is:

  • Children with ADHD will have more caries.
  • Children with ADHD will have more detrimental oral hygiene and diet habits.
  • There will be a difference in the saliva parameters between children with ADHD and healthy children.
Keywords
ADHD, saliva, caries
Medical subject headings
Attention Deficit Disorder with Hyperactivity, Dental Caries, Xerostomia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00966394
Study groupRoleWhat they receive
ADHD medicationChildren with ADHD and pharmacologic treatment
ADHD without medicationChildren with ADHD without pharmacologic treatment
healthyHealthy children ASA1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2009 (estimated)
  2. Study startNov 2009
  3. Primary completionMay 2010
  4. Study completionMay 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00966394
Sponsor's protocol ID
adhd-hmo-ctil
Acronym
ADHD
Status last verified
Aug 2009
First submitted
25 Aug 2009
Last updated
26 May 2010
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Attention Deficit Hyperactivity Disorders and Caries, Dental, run by Hadassah Medical Organization at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 May 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2010; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in